Director Julia P. Gregory awarded 68,693 Biohaven (BHVN) stock options

Rhea-AI Filing Summary

Biohaven Ltd. director Julia P. Gregory received a grant of 68,693 stock options to buy Common Shares at an exercise price of $9.61 per share. The options expire on April 28, 2036 and represent compensation rather than an open-market purchase.

These options will vest in full on the earlier of April 28, 2027 or the date of Biohaven’s 2027 Annual Meeting of Shareholders, provided she continues serving the company through that vesting date. After this award, she holds 68,693 stock options directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider GREGORY JULIA P

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Options (Right to buy)	68,693	$0.00	--

Holdings After Transaction: Stock Options (Right to buy) — 68,693 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Option grant size: 68,693 options Exercise price: $9.61 per share Expiration date: April 28, 2036 +2 more

5 metrics

Option grant size 68,693 options Stock options granted on April 28, 2026

Exercise price $9.61 per share Exercise price for Biohaven Common Shares

Expiration date April 28, 2036 Option term end date

Post-grant option holdings 68,693 options Total stock options held directly after this award

Vesting date trigger Earlier of April 28, 2027 or 2027 Annual Meeting Full vesting condition subject to continuous service

Key Terms

Stock Options (Right to buy), exercise price, vesting, Annual Meeting of Shareholders, +1 more

5 terms

Stock Options (Right to buy) financial

"security_title: "Stock Options (Right to buy)""

exercise price financial

"conversion_or_exercise_price of 9.6100 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"will vest in full on the earlier of (a) April 28, 2027"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Annual Meeting of Shareholders financial

"or (b) the date of the 2027 Annual Meeting of Shareholders"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

Common Shares financial

"underlying_security_title: "Common Shares""

Common shares are the basic units of ownership in a company that give holders a claim on profits and a right to vote on key matters, like electing the board. Think of them as membership cards in a club: they let you share in successes and losses, but in a bankruptcy or liquidation they are paid after creditors and preferred shareholders, so their value can swing more and matters for assessing risk and potential return.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GREGORY JULIA P

(Last) (First) (Middle)

C/O BIOHAVEN LTD.

215 CHURCH STREET

(Street)

NEW HAVEN CONNECTICUT 06510

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Biohaven Ltd. [ BHVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to buy)	$9.61	04/28/2026		A		68,693		(1)	04/28/2036	Common Shares	68,693	$0	68,693	D

Explanation of Responses:

1. The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2027 or (b) the date of the 2027 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date.

Remarks:

	/s/ George Clark, Attorney-in-Fact	04/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Julia P. Gregory receive in this Biohaven (BHVN) Form 4 filing?

Julia P. Gregory received a grant of 68,693 stock options to purchase Biohaven Common Shares at an exercise price of $9.61 per share. This award is compensation, not an open-market stock purchase, and is reported as a derivative security transaction on Form 4.

What are the vesting terms of Julia P. Gregory’s Biohaven (BHVN) stock options?

The 68,693 stock options vest in full on the earlier of April 28, 2027 or the date of Biohaven’s 2027 Annual Meeting of Shareholders. Vesting is conditioned on Ms. Gregory’s continuous service with Biohaven through the applicable vesting date, as disclosed in the footnote.

What is the exercise price and expiration date of the Biohaven (BHVN) options?

The stock options have an exercise price of $9.61 per Common Share and an expiration date of April 28, 2036. This means Ms. Gregory can choose to buy shares at $9.61 any time after vesting and before the options expire, subject to plan terms.

How many Biohaven (BHVN) options does Julia P. Gregory hold after this grant?

Following this award, Julia P. Gregory holds 68,693 stock options directly, each for one Biohaven Common Share. This figure reflects the total derivative position reported in the Form 4 for this specific option grant and does not include any other potential holdings not shown here.

Is Julia P. Gregory buying or selling Biohaven (BHVN) shares in this Form 4?

This Form 4 reports an acquisition of stock options as compensation, not a market trade in existing shares. The transaction code "A" indicates a grant or award, and no open-market buying or selling of Biohaven Common Shares is disclosed in the provided data.